NCT00866684 2025-03-14PROSKINCharite University, Berlin, GermanyPhase 4 Terminated44 enrolled 7 charts
NCT01116232 2019-03-26Sirolimus, Tacrolimus, Thymoglobulin and Rituximab as Graft-versus-Host-Disease Prophylaxis in Patients Undergoing Haploidentical and HLA Partially Matched Donor Hematopoietic Cell TransplantationBarbara Ann Karmanos Cancer InstitutePhase 2 Terminated4 enrolled 4 charts
NCT01166126 2014-05-15Temsirolimus/AZD 6244 for Treatment-naive With BRAF Mutant Unresectable Stage IVNational Cancer Institute (NCI)Phase 2 Terminated4 enrolled 7 charts